Abstract
Symptom-Assessment Application (SAAs) and Large Language Models (LLMs) are increasingly used by laypeople to navigate care options. Although humans ultimately make a final decision when using these systems, previous research has typically examined the performance of humans and SAAs/LLMs separately. Thus, it is unclear how decision-making unfolds in such hybrid human-technology teams and if SAAs/LLMs can improve laypeople’s decisions. To address this gap, we conducted a convergent parallel mixed-methods study with semi-structured interviews and a randomized controlled trial. Our interview data revealed that in human-technology teams, decision-making is influenced by factors before, during, and after interaction. Users tend to rely on technology for information gathering and analysis but remain responsible for information integration and the final decision. Based on these results, we developed a model for technology-assisted self-triage decision-making. Our quantitative results indicate that when using a high-performing SAA, laypeople’s decision accuracy improved from 53.2% to 64.5% (OR = 2.52, p < .001). In contrast, decision accuracy remained unchanged when using a LLM (54.8% before vs. 54.2% after usage, p = .79). These findings highlight the importance of studying SAAs/LLMs with humans in the loop, as opposed to analyzing them in isolation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
DRKS00033775
Funding Statement
They study did not receive any external funding. It was funded by the home institution of the last author.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the Department of Psychology and Ergonomics (IPA) at the Berlin Institute of Technology (tracking numbers AWB_KOP_3_230915 and 2225676) granted ethical approval for this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
